Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole
Chirag G Patel, Li Li, Suzette Girgis, David M Kornhauser, Ernest U Frevert, David W BoultonBristol-Myers Squibb, Princeton, NJ, USABackground: Many medicines, including several cholesterol-lowering agents (eg, lovastatin, simvastatin), antihypertensives (eg, diltiazem, nifedipine, verapamil), and a...
Saved in:
Main Authors: | Patel C (Author), Li L (Author), Girgis S (Author), Kornhauser D (Author), Frevert E (Author), Boulton D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2011-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain
by: Ruparel Shivani, et al.
Published: (2012) -
Pharmacokinetic drug interactions of asciminib with the sensitive cytochrome P450 probe substrates midazolam, warfarin, and repaglinide in healthy participants
by: Matthias Hoch, et al.
Published: (2022) -
Probe substrates assay estimates the effect of polyphyllin H on the activity of cytochrome P450 enzymes in human liver microsomes
by: Erhao Wang, et al.
Published: (2024) -
Simultaneous Determination of Five Cytochrome P450 Probe Substrates and Their Metabolites and Organic Anion Transporting Polypeptide Probe Substrate in Human Plasma Using Liquid Chromatography-Tandem Mass Spectrometry
by: Jae-Kyung Heo, et al.
Published: (2018) -
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
by: Hao Wang, et al.
Published: (2020)